https://www.hl.co.uk/shares/shares-search-results/v/viking-therapeutics-inc-usd0.00001/company-information
Company information for Viking Therapeutics Inc (VKTX) including general stock details, key personnel and important dates for your diary.
viking therapeuticscompany informationinc
https://www.biospace.com/viking-therapeutics-to-present-at-svb-securities-global-biopharma-conference
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and...
viking therapeuticssvb securitiespresentglobalbiopharma
https://www.macrotrends.net/stocks/charts/VKTX/viking-therapeutics/roa
Current and historical return on assets (ROA) values for Viking Therapeutics (VKTX) over the last 10 years. Return on assets can be defined as an indicator of...
viking therapeuticsroamacrotrends
https://www.ainvest.com/news/viking-therapeutics-a-compelling-buy-on-dip-2411101035fee05ba5d9e3fa/
Viking Therapeutics: A Compelling Buy on the Dip?
viking therapeuticscompellingbuydip
https://www.finanznachrichten.de/nachrichten-2026-01/67412828-viking-therapeutics-inc-viking-therapeutics-announces-publication-of-results-from-phase-2-venture-trial-of-dual-glp-1-gip-receptor-agonist-vk2735-i-008.htm
Publication Highlights Impressive Weight Loss of Up to 14.7% from Baseline After 13 Weeks of Treatment; No Plateau Observed VK2735 Currently Being Evaluated in...
viking therapeuticsincannouncespublicationresults
https://www.fool.com/investing/2025/04/02/viking-therapeutics-down-40-reached-milestone/
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
viking therapeuticsreachednewmilestone
https://www.fool.com/investing/2023/06/20/after-blasting-off-881-in-1-year-is-viking-still/
The risks are high, and the rewards are uncertain for new buyers.
viking therapeuticsblastingyear
https://www.fool.com/investing/2019/11/06/up-192-is-viking-therapeutics-stock-still-a-buy.aspx
Can the stock march even higher after its recent rally?
viking therapeuticsstockstillbuy